Amiodarone

This classification denotes a cation channel blocker and antiarrhythmic agent with the molecular formula C25H29I2NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) N3RQ532IUT, chemically known as 2-n-butyl-3,5-diiodo-4-n-diethylaminoethoxy-3-benzoylbenzofuran but more generally known as amiodarone, which bears US NIH Compound Identifier 2157. Amiodarone most often comes in base and hydrochloride forms. European Medicines Agency schedules Amiodarone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05451MIG. The term AMIODARONE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules amiodarone in its Anatomical Therapeutic Chemical (ATC) Classification. AMIODARONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule amiodarone under HS 29329985 and SITC 51569. As of Q4 2014, AMIODARONE remains US FDA's Preferred Term for this commodity. Amiodarone bears US NLM identifiers UMLS ID C0002598 and NCI Concept Code C62002. SMILES: IC1C(OCCN(CC)CC)C(I)CC(C(=O)C2C(OC3C2CCCC3)CCCC)C1.